Doctronic built a collective-intelligence AI platform that conducts structured clinical reasoning with multi-agent models and operates a clinical practice licensed in all 50 states. The company provides free AI consultations 24/7, delivers four potential diagnoses and treatment plans per interaction, and offers optional licensed-physician video visits for a fee or insurance copay. In December 2025 Doctronic became the first AI-native platform authorized to autonomously renew prescriptions under Utah's AI Learning Lab, handling 190 medications under safety protocols including 24/7 escalation to licensed physicians. The company reports rapid commercial traction — 15× growth to eight-figure annualized revenue since the Series A, nearly tripled repeat patient rate, and more than 300,000 unique weekly visitors. Doctronic serves health systems, payers, employers, and millions of direct-to-consumer users, and it has integrations such as QHIN/TEFCA access to patient records, Surescripts medication history, and First Databank drug interaction screening. The company is pursuing regulatory expansion to other states and governments and maintains first-of-its-kind AI medical malpractice insurance where its AI practices autonomously.

Total raised

$60M

Funding rounds

2

Latest round

Series B

Latest activity

Mar 2026